Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds

When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive, potentially life-threatening course than in other children, probably because of delays in diagnosis, researchers at Dana-Farber/Children's Hospital Cancer Center in Boston are reporting at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami, April 24-27. Read more here.